Clinical Trial

ACTing Minds: An ACT-based Videogame for Mental Health

Study acronym: ACTingMindsRCT
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to test whether a single-session Acceptance and Commitment Therapy (ACT) videogame (ACTing Minds) improves psychological flexibility and mental health in adults who report mild to moderate depression, anxiety or stress. The main questions are whether ACTing Minds increases psychological flexibility (CompACT Total) more than a time- and engagement-matched neutral commercial game at the end of the session and again at short-term follow-up (10-13 days), and whether it produces favourable changes in symptoms, wellbeing, social connectedness, health-related quality of life, and short seated heart-rate variability recordings. Researchers will compare ACTing Minds with the neutral game to determine whether the ACT-based experience leads to greater improvements. Participants attend one laboratory visit of about 60 minutes, complete brief questionnaires at baseline, immediately after the session and at short-term follow-up, and provide a short seated ECG at each timepoint for heart-rate variability analysis. The study uses a single-blind, two-arm, randomised, parallel-group design at Swansea University (UK).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-26; most recent amendment 2026-02-09.
Status change: Not Yet Recruiting → Completed 2026-01-15
Trial Details
NCT Number NCT07272096
Lead Sponsor Swansea University
Conditions Depression, Anxiety, Stress (Psychology), Psychological Flexibility, Quality of Life, Social Connectedness, Wellbeing
Enrollment 302 participants
Start Date 2025-11-26
Primary Completion 2025-12-09 (estimated)
Study Completion 2025-12-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-12